Detalhe da pesquisa
1.
[A Case of Intrahepatic Cholangiocarcinoma in Contact with the Gastroduodenal Anastomosis in Which Proton Beam Therapy Was Performed after Placement of an Absorbable Spacer].
Gan To Kagaku Ryoho
; 50(13): 1453-1455, 2023 Dec.
Artigo
em Japonês
| MEDLINE | ID: mdl-38303305
2.
Anti-tumor activity of dual inhibition of phosphatidylinositol 3-kinase and MDM2 against clear cell ovarian carcinoma.
Gynecol Oncol
; 155(2): 331-339, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31493899
3.
Expression of Par3 polarity protein correlates with poor prognosis in ovarian cancer.
BMC Cancer
; 16(1): 897, 2016 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-27855669
4.
PI3K/mTOR pathway inhibition overcomes radioresistance via suppression of the HIF1-α/VEGF pathway in endometrial cancer.
Gynecol Oncol
; 138(1): 174-80, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25913131
5.
Antitumor activity of a combination of dual PI3K/mTOR inhibitor SAR245409 and selective MEK1/2 inhibitor pimasertib in endometrial carcinomas.
Gynecol Oncol
; 138(2): 323-31, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26033306
6.
Anti-tumor activity of olaparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, in cultured endometrial carcinoma cells.
BMC Cancer
; 14: 179, 2014 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-24625059
7.
Sulfated glycosaminoglycans are required for specific and sensitive fibroblast growth factor (FGF) 19 signaling via FGF receptor 4 and betaKlotho.
J Biol Chem
; 286(30): 26418-23, 2011 Jul 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-21653700
8.
Group A Streptococcal Toxic Shock Syndrome after a Routine Gynecological Procedure.
Case Rep Obstet Gynecol
; 2021: 9980015, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34211792
9.
Uterine Torsion in an Elderly Woman Associated with Leiomyoma and Continuously Elevating Muscle Enzymes: A Case Study and Review of Literature.
Case Rep Obstet Gynecol
; 2020: 8857300, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33133709
10.
betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c.
Mol Endocrinol
; 22(4): 1006-14, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18187602
11.
MDM2 is a potential therapeutic target and prognostic factor for ovarian clear cell carcinomas with wild type TP53.
Oncotarget
; 7(46): 75328-75338, 2016 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27659536
12.
Integrated copy number and expression analysis identifies profiles of whole-arm chromosomal alterations and subgroups with favorable outcome in ovarian clear cell carcinomas.
PLoS One
; 10(6): e0128066, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26043110
13.
Sulfated glycosaminoglycan-assisted receptor specificity of human fibroblast growth factor (FGF) 19 signaling in a mouse system is different from that in a human system.
J Biomol Screen
; 18(3): 321-30, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23064887
14.
Correction: Integrated Copy Number and Expression Analysis Identifies Profiles of Whole-Arm Chromosomal Alterations and Subgroups with Favorable Outcome in Ovarian Clear Cell Carcinomas.
PLoS One
; 10(7): e0132751, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26147301